Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
- 28 May 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 31 (11), 967-972
- https://doi.org/10.1038/sj.bmt.1704042
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2002
- Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantationBlood, 2002
- Allogeneic transplantation of CD34+selected cells from peripheral blood from human leukocyte antigen–identical siblings: detrimental effect of a high number of donor CD34+ cells?Blood, 2001
- Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T cell‐depleted peripheral blood stem cell transplants with delayed donor lymphocyte add‐backBritish Journal of Haematology, 2001
- Chronic graft-versus-host disease after allogeneic blood stem cell transplantationBlood, 2001
- Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesBritish Journal of Haematology, 2001
- Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemiaBone Marrow Transplantation, 2001
- A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?Bone Marrow Transplantation, 2000
- CD34+ cell dose predicts relapse and survival after T‐cell‐depleted HLA‐identical haematopoietic stem cell transplantation (HSCT) for haematological malignanciesBritish Journal of Haematology, 2000
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975